MAPT and Alzheimer disease: Tau pathology can lead to synaptic loss, neuroinflammation, and cognitive decline, resulting in the pathogenesis of various tauopathic disorders, such as Alzheimer's disease (AD), progressive supranuclear palsy, corticobasal degeneration, corticobasal degeneration nucleus, and argyrophilic granular disease.